rpr 103611 has been researched along with betulinic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Cosentino, LM; Garrett, PE; Hashimoto, F; Kashiwada, Y; Lee, KH | 1 |
| Bousseau, A; Carry, JC; De Clercq, E; Dereu, N; Evers, M; Hénin, Y; Huet, T; Le Pecq, JB; Mayaux, JF; Pauwels, R; Poujade, C; Soler, F | 1 |
2 other study(ies) available for rpr 103611 and betulinic acid
| Article | Year |
|---|---|
Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents.
Topics: Antiviral Agents; Betulinic Acid; Giant Cells; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Pentacyclic Triterpenes; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Triterpenes; Virus Replication | 1996 |
Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry.
Topics: Antiviral Agents; Betulinic Acid; DNA Nucleotidyltransferases; Enzyme Inhibitors; HIV Envelope Protein gp120; HIV Protease Inhibitors; HIV-1; Humans; Integrases; Molecular Structure; Pentacyclic Triterpenes; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 1996 |